Company News

    RSS Feed

Lexaria Files New Patent Application

Lexaria-Bioscience

June 22, 2017 |

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces the filing of a new provisional patent application and stock and option awards.

Lexaria has successfully filed a new provisional patent application with the US Patent and Trademark Office (“USPTO”), No. 62/519,511, with a filing date of June 14, 2017. The new patent application expands Lexaria’s  … Read More

Isodiol International Inc. establishes operations in Mexico and will commence shipment of cannabinol products

isodol

June 21, 2017 | Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has established operations in Mexico and will commence shipment of its Cannabinol products throughout Mexico within the coming weeks.

With  … Read More

Q Biomed Inc. Finalizes License Agreement With Oklahoma Medical Research Foundation And The Rajiv Gandhi Centre For Biotechnology For Novel Liver Cancer Treatment

Q BioMed logo 1

June 19, 2017 | Q BioMed Inc. (OTCQB:QBIO), is very pleased to announce their entry into a final license agreement with The Oklahoma Medical Research Foundation (OMRF) and the Rajiv Gandhi Centre for Biotechnology (RGCB). Under the agreement QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat  … Read More

Isodiol International inc. commences approval process for its pharmaceutical products through the Brazilian Health Regulatory Agency (ANVISA)

isodol

June 19, 2017 | Isodiol International Inc.(CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has initiated the drug approval process through the Brazilian Health Regulatory Agency (ANVISA) for the approval of its pharmaceutical grade  … Read More

Isodiol International Inc. over subscribes private placement and closes second tranche for total proceeds of $4,142,070 CDN

isodol

June 16, 2017 | Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (FSE: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce the closing of the second tranche of its non-brokered private placement (the “Private Placement”). The second tranche consisted of the  … Read More